← SynDRA
PINACIDIL ANHYDROUS
SynDRA canonical compound SYN0004192 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | ABCC8 |
| Mechanism of action | Potassium channel activator |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- ABCC9
- KCNJ11
- ABCC8
- KCNJ8
- KCNMA1
Mechanisms of action (all sources)
- ATP channel activator
- Potassium channel activator
- KCNJ11 OPENER
- Sulfonylurea receptor 2, Kir6.2 opener
- ABCC9 OPENER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA3
- LMNA
- MAOA
- MPHOSPH8
- NFE2L2
- NPSR1
- OPRM1
- PDE3A
- PDE4A
- PGR
- PMP22
- PTGS1
- RAPGEF4
- SAMHD1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- TBXA2R
- KDR
- KCNH2
- HTR2B
- CYP3A4
- ADRA1A
- ADRA2A
- ALDH1A1
- AR
- BLM
- CBX1
- CHRM1
- CHRM2
- DRD1
- HTR1A
- DRD3
- EHMT2
- ESR1
- F2
- GLA
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- MDR1
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
- Membrane Transport Modulators
- Vasodilator Agents
ATC classes
- C02D · ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- PINDAC
- pinacidil
- (R,S)-Pinacidil
- pinacidil monohydrate
- pindac
- (+/-)-Pinacidil
- pinacidil hydrate
- (r,s)-pinacidil
- P-1134
- S-1230
- Pinacidil
- Pinacidilum
- P 1134
- P-154
- Pinacidil (anhydrous)
- Pinacidilum [INN-Latin]
- (+-)-Pinacidil
- Pinacidil [INN]
- MLS000069377
- SMR000058360
- P-1134;S-1230
- SR-01000075340
- SR-05000001757
- NCGC00025188-04
- EINECS 262-294-9
- UNII-BB4UGO5K0D
- Prestwick_396
- Pinacidil (Standard)
- Spectrum_000387
- SpecPlus_000759
- PINACIDIL [MI]
- Opera_ID_1844
- Prestwick0_000246
- Prestwick1_000246
- Prestwick2_000246
- Prestwick3_000246
- Spectrum2_001739
- Spectrum5_001372
- PINACIDIL [WHO-DD]
Look up PINACIDIL ANHYDROUS in the interactive SynDRA portal →